Breast cancer and endometriosis drug Zoladex is being pulled from Australia. How will women be affected?
Manufactured by AstraZeneca, Zoladex provides pain relief for women with endometriosis and is a treatment for breast cancer. Photograph: Olena Malik/Getty ImagesView image in fullscreenManufactured by AstraZeneca, Zoladex provides pain relief for women with endometriosis and is a treatment for breast cancer. Photograph: Olena Malik/Getty ImagesHealthBreast cancer and endometriosis drug Zoladex is being pulled from Australia.
- ▪Manufactured by AstraZeneca, Zoladex provides pain relief for women with endometriosis and is a treatment for breast cancer.
- ▪Photograph: Olena Malik/Getty ImagesView image in fullscreenManufactured by AstraZeneca, Zoladex provides pain relief for women with endometriosis and is a treatment for breast cancer.
- ▪Photograph: Olena Malik/Getty ImagesHealthBreast cancer and endometriosis drug Zoladex is being pulled from Australia.
The Guardian — World publishes from United Kingdom and files mainly under world. We currently carry 2,120 of its stories.
Opening excerpt (first ~120 words) tap to expand
Manufactured by AstraZeneca, Zoladex provides pain relief for women with endometriosis and is a treatment for breast cancer. Photograph: Olena Malik/Getty ImagesView image in fullscreenManufactured by AstraZeneca, Zoladex provides pain relief for women with endometriosis and is a treatment for breast cancer. Photograph: Olena Malik/Getty ImagesHealthBreast cancer and endometriosis drug Zoladex is being pulled from Australia. How will women be affected?The vital medicine, made by AstraZeneca, will not be available from November, possibly leaving thousands of women without treatment Get our breaking news email, free app or daily news podcast Krishani DhanjiWed 10 Jun 2026 11.00 EDTSharePrefer the Guardian on GoogleThousands of women could be left without vital breast cancer and…
Excerpt limited to ~120 words for fair-use compliance. The full article is at World news | The Guardian.
Discussion
0 commentsMore from World news | The Guardian
